It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Maturity Onset Diabetes of the Young (MODY) is a young-onset, monogenic form of diabetes without needing insulin treatment. Diagnostic testing is expensive. To aid decisions on who to test, we aimed to develop a MODY probability calculator for paediatric cases at the time of diabetes diagnosis, when the existing “MODY calculator” cannot be used. Firth logistic regression models were developed on data from 3541 paediatric patients from the Swedish ‘Better Diabetes Diagnosis’ (BDD) population study (n = 46 (1.3%) MODY (HNF1A, HNF4A, GCK)). Model performance was compared to using islet autoantibody testing. HbA1c, parent with diabetes, and absence of polyuria were significant independent predictors of MODY. The model showed excellent discrimination (c-statistic = 0.963) and calibrated well (Brier score = 0.01). MODY probability > 1.3% (ie. above background prevalence) had similar performance to being negative for all 3 antibodies (positive predictive value (PPV) = 10% v 11% respectively i.e. ~ 1 in 10 positive test rate). Probability > 1.3% and negative for 3 islet autoantibodies narrowed down to 4% of the cohort, and detected 96% of MODY cases (PPV = 31%). This MODY calculator for paediatric patients at time of diabetes diagnosis will help target genetic testing to those most likely to benefit, to get the right diagnosis.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details







1 University of Exeter, The Department of Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, Exeter, UK (GRID:grid.8391.3) (ISNI:0000 0004 1936 8024)
2 Skånes University Hospital, Lund, Sweden (GRID:grid.411843.b) (ISNI:0000 0004 0623 9987)
3 Imperial College London, Faculty of Medicine, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111)
4 The Royal Devon University Healthcare NHS Foundation Trust, Exeter Genomics Laboratory, Exeter, UK (GRID:grid.7445.2)
5 Lund University, Department of Clinical Sciences Malmö, Lund, Sweden (GRID:grid.4514.4) (ISNI:0000 0001 0930 2361); Skånes University Hospital, Department of Pediatrics, Malmö, Sweden (GRID:grid.411843.b) (ISNI:0000 0004 0623 9987)
6 Sahlgrenska Academy, University of Gothenburg, Department of Paediatrics, Institute for Clinical Sciences, Gothenburg, Sweden (GRID:grid.8761.8) (ISNI:0000 0000 9919 9582); Sahlgrenska University Hospital, Queen Silvia Children’s Hospital, Region Västra Götaland, Department of Paediatrics, Gothenburg, Sweden (GRID:grid.1649.a) (ISNI:0000 0000 9445 082X)
7 Linköping University, Crown Princess Victoria Children’s Hospital and Division of Pediatrics, Linköping, Sweden (GRID:grid.5640.7) (ISNI:0000 0001 2162 9922)